IntelGenx Receives Approval to Conduct 'MONTPARK' Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's Disease : vimarsana.com

IntelGenx Receives Approval to Conduct 'MONTPARK' Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's Disease

IntelGenx Receives Approval to Conduct 'MONTPARK' Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's Disease

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Quebec , Canada , Saint Laurent , Sweden , Swedish , Canadian , Stephen Kilmer , Intelgenx Montelukast Versafilm , Dwight Gorham , Andre Godin , Montelukast Versafilm , Intelgenx Corp , Swedish University , Swedish Research Council , Intelgenx Technologies Corp , Exchange Commission , Regional Biobank Centre , Swedish Ethical Review Authority , Company Or Intelgenx , Securities Exchange , World Health Organization , Karolinska University Hospital , Swedish Medical Products Agency , Parkinson Foundation , Per Svenningsson , Swedish Crowns , Intelgenx Montelukast , Health Organization , Leukotriene Receptor Antagonist Montelukast , Looking Information , Securities Exchange Act , Securities Act , United States Securities , Intelgenx Technologies ,